Skip to main content
. 2020 Mar 13;11:110. doi: 10.3389/fendo.2020.00110

Table 1.

Patient characteristic of the included studies.

Study Country Design No. of patients Age Male BMI Ischemic etiology HFrEF NYHA class LVEF T2DM AF SBP DBP
Years % kg/m2 % % % % % mmHg mmHg
Pugh et al. (14) UK R, DB, PC 20 61.5 100 28.8 60.0 100 2.4 35.0 NR NR 133 78
Malkin et al. (15) UK R, DB, PC 76 64.0 100 27.8 53.9 100 2.5 33.5 17.1 NR 130 78
Caminiti et al. (16) Italy R, DB, PC 70 70.0 100 26.3 77.1 100 2.5 32.7 28.6 37.1 127 91
Iellamo et al. (17) Italy R, DB, PC 32 68.6 0 27.9 100. 100 3.0 32.9 53.1 28.1 114 78
Stout et al. (18) UK R, DB, PC 28 67.2 100 29.3 71.4 100 2.5 24.4 32.1 35.7 138 82
Mirdamadi et al. (19) Iran R, DB, PC 50 60.5 100 26.5 NR 100 2.4 32.1 26.0 NR 123 80
Dos Santos et al. (20) Brazil R, DB 27 52.0 100 NR 51.8 100 3.0 25.5 NR NR 115 67
Navarro-Penalver et al. (21) Spain R, DB, PC 29 65 100 30 62 100 2.3 30 48.3 37.9 NR NR

BMI, body mass index, HFrEF, heart failure with reduced ejection fraction; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; T2DM, type 2 diabetes mellitus; AF, atrial fibrillation; SBP, systolic blood pressure; DBP, diastolic blood pressure; NR, not reported; R, randomized; DB, double blinded; PC, placebo controlled.